Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Annika Döhmen
Observed name:
Annika Doehmen
Institutions:
Medizinische Hochschule Brandenburg Theodor Fontane,
Universitätsklinikum Brandenburg an der Havel,
Stiftung Charité,
Charité – Universitätsmedizin Berlin
Observed institutions:
Medizinische Hochschule Brandenburg Theodor Fontane,
Universitätsklinikum Brandenburg an der Havel,
Stiftung Charité,
Charité – Universitätsmedizin Berlin
ORCID:
0000-0002-9836-2557
Observed ORCID:
0000-0002-9836-2557
OpenAlex ID:
A5031851861
Are OMERACT recommendations followed in clinical trials on fibromyalgia? A systematic review of patient-reported outcomes and their measures
2022
·
Annika Döhmen
, Milan Kock
, et al.
·
Quality of Life Research
·
17
PDF
The EORTC QLU-C10D distinguished better between cancer patients and the general population than PROPr and EQ-5D-5L in a cross-sectional study
2024
·
Annika Döhmen
, Alexander Obbarius
, et al.
·
Journal of Clinical Epidemiology
·
4
PDF
The PROPr can be measured using different PROMIS domain item sets
2024
·
Christoph Paul Klapproth
, Felix Fischer
, et al.
·
Cancer Epidemiology
·
2
Responsiveness, Test-Retest Reliability, and Minimal Important Change of QLU-C10D, PROPr, and EQ-5D-5L in Cancer Patients
2026
·
Antje Förster
, Alexander Obbarius
, et al.
·
Value in Health
Understanding Health-related quality of life in rheumatologic diseases: insights from PROMIS® health domains
2026
·
Milan Kock
, Christoph Paul Klapproth
, et al.
·
Journal of Patient-Reported Outcomes
Understanding Health-related quality of life in rheumatologic diseases: insights from PROMIS® health domains
2026
·
Milan Kock
, Christoph Paul Klapproth
, et al.
·
Figshare
The PROPr and QLU-C10D are more responsive to change than the EQ-5D-5L in cancer patients
2025
·
Antje Förster
, Alexander Obbarius
, et al.
·
Advances in Patient-Reported Outcomes
Identification of potential treatment targets in rheumatology: How PROMIS domains predict HrQOL in patients
2025
·
Milan Kock
, Christoph Paul Klapproth
, et al.
·
Advances in Patient-Reported Outcomes
The EORTC QLU-C10D and its dimensions distinguish best between health conditions in oncology patients
2025
·
Annika Döhmen
, Alexander Obbarius
, et al.
·
Advances in Patient-Reported Outcomes
Show more works
View as search
Works count:
10
Citation count:
23
H-index:
2
I10-index:
1
Year
Topic
Type